Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Stent For Life Observatory (SFL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Martine Gilard, French Cardiology Society
ClinicalTrials.gov Identifier:
NCT01251198
First received: November 30, 2010
Last updated: June 13, 2012
Last verified: June 2012
  Purpose

Observatory multicenter, prospective, to support the acute phase of acute coronary syndromes with ST segment elevation ST (myocardial infarction).


Condition
Acute Coronary Syndrome
Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Stent For Life Observatory

Resource links provided by NLM:


Further study details as provided by French Cardiology Society:

Enrollment: 460
Study Start Date: November 2010
Study Completion Date: March 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Acute coronary Syndrome
Patients affected are patients with acute coronary syndrome with ST segment elevation ST (myocardial infarction) in 48 hospitalized in one of the centers (emergency, ambulance, intensive care unit, cardiac catheterization lab).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients affected are patients with acute coronary syndrome with ST segment elevation ST (myocardial infarction) in 48 hospitalized in one of the centers (emergency, ambulance, intensive care unit, cardiac catheterization lab).

Criteria

Inclusion Criteria:

  • Any patient with a myocardial infarction less than 48 hours during the November 2010 is eligible and should be considered for inclusion in the study.
  • Every patient who agreed to participate in the study

Exclusion Criteria:

  • Patients with myocardial infarction after a coronary revascularization, or after cardiac surgery or extra heartbeat.
  • Patient denying that his personal data are subject to treatment automated
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01251198

Locations
France
CHU Brest
Brest, France
Sponsors and Collaborators
French Cardiology Society
Investigators
Principal Investigator: Martine Gilard AP-HP
  More Information

Publications:
Responsible Party: Martine Gilard, Professor, French Cardiology Society
ClinicalTrials.gov Identifier: NCT01251198     History of Changes
Other Study ID Numbers: Stent For Life
Study First Received: November 30, 2010
Last Updated: June 13, 2012
Health Authority: France : CNIL
France : CCTIRS

Additional relevant MeSH terms:
Acute Coronary Syndrome
Infarction
Myocardial Infarction
Angina Pectoris
Cardiovascular Diseases
Chest Pain
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pain
Pathologic Processes
Signs and Symptoms
Vascular Diseases

ClinicalTrials.gov processed this record on November 27, 2014